Tamoxifen Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 20 mg, 40 mg
Reference Brands: Nolvadex® , Soltamox®(US & EU)
Category:
Oncology Cancer Care
Tamoxifen is a key oncology drug used to treat and prevent hormone receptor-positive breast cancer. Available in 10 mg, 20 mg, and 40 mg tablets, it's marketed under Nolvadex®, Soltamox®, and generics across the US and EU. GMP-compliant and ideal for B2B pharma supply.
Tamoxifen is available in Tablet
and strengths such as 10 mg, 20 mg, 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tamoxifen is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tamoxifen can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tamoxifen is a widely used oncology medication indicated for the treatment and prevention of hormone receptor-positive breast cancer in pre- and postmenopausal women. As a selective estrogen receptor modulator (SERM), it blocks estrogen’s effects in breast tissue, reducing the risk of cancer growth. Tamoxifen is available in 10 mg, 20 mg, and 40 mg oral tablet forms and marketed under brands like Nolvadex® and Soltamox®, as well as multiple generic alternatives in the US and EU. Ideal for pharma B2B buyers, Tamoxifen is manufactured under GMP compliance, ensuring reliable supply for oncology distributors and tender markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing